newsfilter
← Latest News
GlobeNewswire·

ATAI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of AtaiBeckley to Eli Lilly

  • Wohl & Fruchter LLP is investigating the fairness of the proposed sale of AtaiBeckley, Inc. (NASDAQ: ATAI) to Eli Lilly & Company.
  • The transaction would provide AtaiBeckley shareholders with $6.75 per share in cash plus a contingent value right (CVR) worth up to an additional $2.50 per share.
  • The total sale price is significantly below price targets set by multiple Wall Street analysts, including Patrick Trucchio ($25.00), Sumant Kulkarni ($17.00), Jay Olson ($16.00), Eddie Hickman ($16.00), & Harry Gillis ($14.00).
  • AtaiBeckley shareholders have expressed disappointment regarding the low sale price on the Seeking Alpha investment website.
  • The law firm is examining whether the AtaiBeckley Board of Directors acted in the best interests of shareholders & whether all material information was fully disclosed.
  • Shareholders with concerns regarding the acquisition may contact Wohl & Fruchter LLP via their website, phone, or email at no charge.